Alta Sciences

APRIL 8, 2025

Systemic exposure to ophthalmic medications is influenced by several factors, including the high concentration of active ingredients in eye drops, administration techniques that impact absorption, and patient populations, such as infants, pregnant or nursing women, and the elderly are more susceptible to systemic side effects.

Clinical Trials 52

Clinical Trials Nurses Trials Compliance 52

Perficient: Drug Development

JUNE 26, 2023

Our recent discussions with Chief Medical Officers, Chief Information Officers, Chief Medical Information Officers, and a VP over Nursing point to this: AI can provide a huge amount of value when it comes to care delivery (e.g., point of care). You may notice that I mentioned AI there and not, more specifically, generative AI.

Nurses 52

Nurses Doctors Hospitals Engineering 52

Drug Target Review

AUGUST 16, 2024

Advances in gene editing, personalised medicine, and regenerative therapies are improving patient outcomes and changing the landscape of healthcare. I visited several clinics that we supported through this programme around the US, observing the impact holistic, community-focused care can have on the people who need it most.

Medical Schools 111

Medical Schools Nurses Research Production 111

The Pharma Data

JUNE 28, 2021

To be considered for the Leonard Award, nominees will be required to submit an original project, innovation, or effort – beyond drug or device therapy – that addresses either an important need or challenge in the management of diabetes or aims to support the community. vice president of Lilly Diabetes Global Medical Affairs.

Nurses 52

Nurses International Research Therapies 52

Olympian Clinical Research

JUNE 25, 2020

Changes in living situation, such as moving to a new residence home or nursing home. Make time for soothing activities such as massage therapy, calming music, and reading. Environmental changes such as travel, hospitalization, new visitors, etc. The introduction of a new caregiver. Misperceived threats. Fear and fatigue.

Nurses 78

Nurses Clinical Research Clinical Trials Hospitals 78

The Pharma Data

OCTOBER 21, 2020

“I’m not surprised that they could see similar effects of therapy with patients using telemedicine as they would via in person,” said Dr. Andrew Southerland, an associate professor of neurology and public health sciences at University of Virginia Health, in Charlottesville, Va.

Therapies 52

Therapies Nurses Compliance Doctors 52

The Pharma Data

DECEMBER 10, 2020

To cheer her up, the nurses decorated her room with class of 2015 memorabilia. She spent weeks undergoing physical, occupational and speech therapy. “Just as he was hugging me, one of my nurses came in and immediately broke down and started crying,” she said. Later, she did the same thing for one of her doctors.

Nurses 52

Nurses Doctors Hospitals Therapies 52

The Pharma Data

DECEMBER 10, 2020

She’s an associate dean of research at Indiana University School of Nursing, in Indianapolis. “We don’t know if hormone therapy addresses this symptom specifically, but it does tend to address menopause symptoms globally. So often you will see them anecdotally go away when we put women on hormone therapy.”

Doctors 52

Doctors Nurses Therapies Clinical Trials 52

The Pharma Data

NOVEMBER 10, 2020

SAMI is a renal replacement therapy (RRT) machine manufactured and commercialized by Spectral’s wholly-owned subsidiary, Dialco Medical Inc. ( “Dialco” ). The paper describes the first month of using SAMI as part of UMMC’s PIRRT (Prolonged Intermittent Renal Replacement Therapy) program throughout April 2020.

Therapies 52

Therapies FDA Nurses FDA Approval 52

The Pharma Data

APRIL 8, 2021

FDA and global approvals for our groundbreaking therapies in SMA and NMOSD, Roche’s data at AAN reflect our continued commitment to meaningful therapeutic progress for people living with neurological disorders,” said Levi Garraway, M.D., Following U.S. Roche’s Chief Medical Officer and Head of Global Product Development. Claims Database.

Clinical Trials 52

Clinical Trials Trials Disease Therapies 52

KIF1A

APRIL 27, 2024

Where’s the best therapy? We sold our house, I gave up my career as a nurse, and we moved to Calgary. “I immediately started researching where in Canada has the best resources for Emma. Where’s the best schools? Where’s the best support?” Amanda says. “We We left our whole lives behind.

Doctors 52

Doctors Nurses Disease Therapies 52

The Pharma Data

JANUARY 19, 2021

The new findings were published online recently in the Journal of Pediatric Nursing. “This is a study of pets or companion animals as opposed to service or therapy animals, so it is something that any family could pursue and gives a roadmap of how to do it well for families who are interested.” © 2021 HealthDay.

Nurses 52

Nurses Hospitals Research Science 52

The Pharma Data

AUGUST 6, 2020

In 2016, data became increasingly available on the safety profile of fluoroquinolone antibiotics, specifically around inappropriate use as a first-line therapy which raised concern of potential harm to patients. The history of fluoroquinolones. Medscape and the FDA collaborative research. This target audience wrote 7.3

FDA 52

FDA Nurses Hospitals Therapies 52

The Pharma Data

NOVEMBER 20, 2020

” Debra Moser, a professor and assistant dean at the University of Kentucky College of Nursing in Lexington, said the new study shows that health care professionals need to do a better job of managing depression. Medications, talk therapy and exercise can help, Moser and Celano said.

Disease 52

Disease Nurses Research Hospitals 52

The Pharma Data

NOVEMBER 17, 2020

She speaks nationally and internationally on how cancer and autoimmune disease therapies affect reproductive health and fertility, ovarian aging, primary ovarian insufficiency and genetics. Hammond , DNP, CRNP is a board-certified Nurse Practitioner, is IVF Program Director at AIRM. Karen R. Karen R.

Laboratories 52

Laboratories Nurses Doctors International 52

The Pharma Data

DECEMBER 17, 2020

If the therapy proves safe and effective in clinical trials and regulatory approvals are granted, Regeneron will manufacture and distribute it in the U.S. , Authorized Emergency Use Casirivimab and imdevimab injection is an investigational combination therapy and has been authorized by FDA for the emergency use described above.

Hospitals 52

Hospitals Production Clinical Trials Virus 52

The Pharma Data

APRIL 28, 2023

We are committed to supporting patients through innovative therapy options. 10 Companion survey data were collected from 63 patients, 24 physicians, and 25 nurses in a prospective, cross-sectional companion survey assessing the perceptions regarding ease of use and satisfaction with UZEDY.

FDA Approval 40

FDA Approval Treatment FDA Clinical Trials 40

The Pharma Data

OCTOBER 25, 2020

Treatment choices are limited, and commonly used off-label therapies are not always effective or may result in prolonged, deep sedation. A therapy that quickly and effectively reduces agitation, without causing excessive sedation, is needed to speed up recovery time and improve patient outcomes. NEW HAVEN, Conn.,

Treatment 40

Treatment Trials FDA Hospitals 40

The Pharma Data

JULY 23, 2021

20% reduction in lesion size compared to baseline and no receipt of rescue antibacterial therapy for children 3 months and older. There are no adequate and well-controlled studies with DALVANCE use in pregnant or nursing women. This analysis evaluated an early clinical response at 48 to 72 hours based on achieving a ?

FDA Approval 52

FDA Approval FDA Clinical Trials Trials 52

Altus Drug Development

MAY 31, 2022

This lightens the burden that patients in critical condition put on healthcare systems, giving doctors and nurses some much-needed breathing space. For healthcare professionals Value-added medicines group several choices together, creating an unprecedented amount of flexibility in therapy.

Treatment 52

Treatment Pharmaceuticals Production Doctors 52

On Medicine

FEBRUARY 26, 2023

In addition to meaningful specialized treatment, Daniella uses her creative pursuits as a form of therapy, inspiring others living with chronic health issues through the use of her podcast.

Disease 40

Disease Treatment Nurses Doctors 40

The Pharma Data

NOVEMBER 30, 2020

The Company is proud to partner with an extensive and highly diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid and commercial insurance payors. AdaptHealth services approximately 1.8

Compliance 40

Compliance Nurses Production Therapies 40

The Pharma Data

MAY 18, 2021

3 After surgery, patients may receive additional treatments to help lower the risk of the cancer returning, such as targeted therapies. As a nursing student, Jordan understood the seriousness of the cancer having spread to her lymph nodes. . Surgery to remove the cancerous cells is usually the first treatment for stage III melanoma.

Nurses 52

Nurses Doctors DNA Treatment 52

The Pharma Data

FEBRUARY 1, 2021

1, 2021 — As America’s vaccination campaign begins to gain momentum, a promising sign has emerged: Federal data shows that coronavirus cases in nursing homes have declined over the past four weeks. The country recorded 17,584 cases in nursing homes during the week ending Jan. MONDAY, Feb.1, 17, The New York Times reported.

Nurses 52

Nurses Vaccine Long-Term Care Facilities Virus 52

The Pharma Data

MARCH 25, 2021

With more than six years of patient experience, a positive benefit-risk profile, strong clinical data and robust real-world data, the totality of evidence solidifies the role of IBRANCE plus endocrine therapy as a treatment for patients with HR+, HER2- metastatic breast cancer.”. The analysis also showed the two-year OS rate was 78.3%

Therapies 52

Therapies Clinical Trials Trials Treatment 52

The Pharma Data

NOVEMBER 20, 2020

NASDAQ: REGN) today announced that the antibody cocktail casirivimab and imdevimab administered together (formerly known as REGN-COV2 or REGEN-COV2), a therapy currently being investigated for use in COVID-19 , has received Emergency Use Authorization (EUA) from the U.S. TARRYTOWN, N.Y., November 21, 2020 – Regeneron Pharmaceuticals, Inc.

Therapies 52

Therapies FDA Clinical Trials Hospitals 52

The Pharma Data

AUGUST 11, 2020

.–( BUSINESS WIRE )– Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 CheckMate -577 trial evaluating Opdivo (nivolumab) as an adjuvant therapy for patients with resected esophageal or gastroesophageal junction (GEJ) cancer met its primary endpoint of disease-free survival (DFS) at a pre-specified interim analysis.

Therapies 52

Therapies Trials Disease Treatment 52

The Pharma Data

JANUARY 12, 2021

. “Patients in our antibody cocktail outpatient clinical trial experienced significant reductions in virus levels and required fewer medical visits for COVID-19, suggesting the therapy can help reduce the current burden on hospitals and healthcare systems,” said George D. who require oxygen therapy due to COVID-19, OR.

Government 52

Government Hospitals Virus Clinical Trials 52

The Pharma Data

AUGUST 27, 2020

The anti-PD-1 therapy combo was approved in Europe in September 2019 based on findings from the pivotal Phase III KEYNOTE-426 trial, which demonstrated that the drug reduced the risk of death by 47% compared with sunitinib in the indication. Kidney cancer UK has slammed the decision.

Clinical Trials 52

Clinical Trials Nurses Trials Treatment 52

The Pharma Data

AUGUST 3, 2021

Food & Drug Administration (FDA) for Istodax ® (romidepsin), a histone deacetylase (HDAC) inhibitor, as monotherapy for the treatment of peripheral T-cell lymphoma (PTCL) in adult patients who have received at least one prior therapy. Bristol Myers Squibb is notifying healthcare professionals about the withdrawal. About Istodax.

Nurses 52

Nurses Treatment Clinical Trials Therapies 52

The Pharma Data

NOVEMBER 19, 2020

A study out of Rutgers University found that healthcare staffers, especially nurses, have a higher prevalence of COVID-19 than non-healthcare workers. Of the 40 healthcare workers who tested positive of the study group, 25 were nurses. Here’s a look at some of the more interesting ones. Healthcare Workers Most at Risk for COVID-19.

Research 52

Research Nurses Disease Immune Response 52

The Pharma Data

DECEMBER 3, 2020

An initial analysis of data from 17/22 patients who completed one of these assessments showed substantially decreased neurocognitive abilities compared to children of the same age level despite the use of multiple anti-epileptic therapies. In addition, a gap in adaptive functioning was noted using the Vineland Adaptive Behavior Scales.

Clinical Trials 52

Clinical Trials Protein Expression Pharmacokinetics Trials 52

The Pharma Data

NOVEMBER 21, 2020

NASDAQ: REGN) today announced that the antibody cocktail casirivimab and imdevimab administered together (also known as REGN-COV2 or REGEN-COV2), a therapy currently being investigated for use in COVID-19, has received Emergency Use Authorization (EUA) from the U.S. who require oxygen therapy due to COVID-19, OR. Schleifer , M.D.,

FDA 40

FDA Clinical Trials Hospitals Production 40

The Pharma Data

DECEMBER 29, 2020

First antibody therapy to demonstrate anti-viral effect in patients hospitalized with COVID-19. Patients were randomized to receive the antibody cocktail (either 8,000 mg high dose or 2,400 mg low dose) or placebo, in addition to standard-of-care therapies, with 67% receiving remdesivir and 74% receiving systemic corticosteroids.

Hospitals 52

Hospitals Trials Clinical Trials Production 52

The Pharma Data

NOVEMBER 18, 2020

It is the partnership of the USF Health Morsani College of Medicine, the College of Nursing, the College of Public Health, the Taneja College of Pharmacy, the School of Physical Therapy and Rehabilitation Sciences, the Biomedical Sciences Graduate and Postdoctoral Programs, and USF Health’s multispecialty physicians group.

Hospitals 40

Hospitals Treatment Virus Nurses 40

The Pharma Data

AUGUST 11, 2020

In the field of immune cell therapy, this includes registrational CAR T cell agents for numerous diseases, and a growing early-stage pipeline that expands cell and gene therapy targets, and technologies. This indication is approved under accelerated approval based on overall response rate and duration of response.

Treatment 52

Treatment Trials Therapies Clinical Trials 52

The Pharma Data

JANUARY 26, 2021

Data published last week showed that bamlanivimab significantly reduced COVID-19 risk for nursing home residents in a Phase III trial. . Eli Lilly’s bamlanivimab, a neutralizing antibody initially developed by AbCellera, was approved for emergency use authorization in November by the U.S.

Virus 52

Virus Trials Nurses Research Laboratories 52